Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,432 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis.
Romani L, Oikonomou V, Moretti S, Iannitti RG, D'Adamo MC, Villella VR, Pariano M, Sforna L, Borghi M, Bellet MM, Fallarino F, Pallotta MT, Servillo G, Ferrari E, Puccetti P, Kroemer G, Pessia M, Maiuri L, Goldstein AL, Garaci E. Romani L, et al. Among authors: ferrari e. Nat Med. 2017 May;23(5):590-600. doi: 10.1038/nm.4305. Epub 2017 Apr 10. Nat Med. 2017. PMID: 28394330 Free PMC article.
Author Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis.
Romani L, Oikonomou V, Moretti S, Iannitti RG, D'Adamo MC, Villella VR, Pariano M, Sforna L, Borghi M, Bellet MM, Fallarino F, Pallotta MT, Servillo G, Ferrari E, Puccetti P, Kroemer G, Pessia M, Maiuri L, Goldstein AL, Garaci E. Romani L, et al. Among authors: ferrari e. Nat Med. 2018 Sep;24(9):1481. doi: 10.1038/s41591-018-0100-0. Nat Med. 2018. PMID: 29934534
Publisher Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis.
Romani L, Oikonomou V, Moretti S, Iannitti RG, D'Adamo MC, Villella VR, Pariano M, Sforna L, Borghi M, Bellet MM, Fallarino F, Pallotta MT, Servillo G, Ferrari E, Puccetti P, Kroemer G, Pessia M, Maiuri L, Goldstein AL, Garaci E. Romani L, et al. Among authors: ferrari e. Nat Med. 2018 Sep;24(9):1482. doi: 10.1038/s41591-018-0099-2. Nat Med. 2018. PMID: 29934535
Autophagy suppresses the pathogenic immune response to dietary antigens in cystic fibrosis.
Villella VR, Esposito S, Ferrari E, Monzani R, Tosco A, Rossin F, Castaldo A, Silano M, Marseglia GL, Romani L, Barlev NA, Piacentini M, Raia V, Kroemer G, Maiuri L. Villella VR, et al. Among authors: ferrari e. Cell Death Dis. 2019 Mar 15;10(4):258. doi: 10.1038/s41419-019-1500-x. Cell Death Dis. 2019. PMID: 30874543 Free PMC article.
A pathogenic role for cystic fibrosis transmembrane conductance regulator in celiac disease.
Villella VR, Venerando A, Cozza G, Esposito S, Ferrari E, Monzani R, Spinella MC, Oikonomou V, Renga G, Tosco A, Rossin F, Guido S, Silano M, Garaci E, Chao YK, Grimm C, Luciani A, Romani L, Piacentini M, Raia V, Kroemer G, Maiuri L. Villella VR, et al. Among authors: ferrari e. EMBO J. 2019 Jan 15;38(2):e100101. doi: 10.15252/embj.2018100101. Epub 2018 Nov 29. EMBO J. 2019. PMID: 30498130 Free PMC article.
Nebulized hyaluronan ameliorates lung inflammation in cystic fibrosis mice.
Gavina M, Luciani A, Villella VR, Esposito S, Ferrari E, Bressani I, Casale A, Bruscia EM, Maiuri L, Raia V. Gavina M, et al. Among authors: ferrari e. Pediatr Pulmonol. 2013 Aug;48(8):761-71. doi: 10.1002/ppul.22637. Epub 2012 Jul 23. Pediatr Pulmonol. 2013. PMID: 22825912
Genistein antagonizes gliadin-induced CFTR malfunction in models of celiac disease.
Esposito S, Villella VR, Ferrari E, Monzani R, Tosco A, Rossin F, D'Eletto M, Castaldo A, Luciani A, Silano M, Bona G, Marseglia GL, Romani L, Piacentini M, Raia V, Kroemer G, Maiuri L. Esposito S, et al. Among authors: ferrari e. Aging (Albany NY). 2019 Apr 12;11(7):2003-2019. doi: 10.18632/aging.101888. Aging (Albany NY). 2019. PMID: 30981209 Free PMC article.
A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR.
Tosco A, De Gregorio F, Esposito S, De Stefano D, Sana I, Ferrari E, Sepe A, Salvadori L, Buonpensiero P, Di Pasqua A, Grassia R, Leone CA, Guido S, De Rosa G, Lusa S, Bona G, Stoll G, Maiuri MC, Mehta A, Kroemer G, Maiuri L, Raia V. Tosco A, et al. Among authors: ferrari e. Cell Death Differ. 2016 Aug;23(8):1380-93. doi: 10.1038/cdd.2016.22. Epub 2016 Apr 1. Cell Death Differ. 2016. PMID: 27035618 Free PMC article. Clinical Trial.
1,432 results